Search results

• December 4 2019

  Liver fibrosis could be treated with gold nanoparticles

  Researchers at IDIBAPS, CIBERehd and ICFO implement gold nanoparticles and plasmonics to treat liver fibrosis in mice.

  Notícias
• December 11 2019

  A new biological treatment could replace chemotherapy in patients with aggressive breast cancer

  Today the results of the phase 2 CORALLEEN clinical trial, promoted by the international academic group SOLTI, have been presented. The study, publ...

  Notícias
• December 13 2019

  Immunotherapy: an innovative and efficient tool in the battle against haematological tumours

  In recent years, one of the strategies developed in the field of haematology is the modification of the patient’s immune system, also known as ‘imm...

  Notícias
• December 16 2019

  How to enjoy the Christmas holidays without putting on weight

  Numerous studies have shown that most people put on weight over the Christmas holidays. Huge meals and a lack of physical exercise are two reasons...

  Notícias
• December 19 2019

  IDIBAPS and Fundació Clínic wish you a Merry Christmas!

  Notícias
• January 9 2020

  Biological diagnosis of schizophrenia: the future

  Schizophrenia is a very heterogeneous disease, patients who suffer this may present a variety of symptoms. In addition, there is currently no analy...

  Notícias
• January 14 2020

  Are electronic cigarettes safe for your health?

  In recent years, electronic cigarettes have appeared on the market, and sales of these have been very successful. In many cases, these systems have...

  Notícias
• January 22 2020

  Using dating apps increases the spread of sexually transmitted infections

  Using new technologies, mainly mobile apps and online platforms, allows people to find potential sexual partners nearby. According to various resea...

  Notícias
• January 27 2020

  New cooking techniques for potassium control achieve better results in less time

  For patients with chronic kidney disease, potassium is an important nutrient that needs to be controlled to prevent potential adverse effects. This...

  Notícias
• February 5 2020

  New monoclonal antibody treatment for non-infectious uveitis

  Uveitis is a disease that causes inflammation of the tissues inside the eye. More specifically, non-infectious uveitis (NIU) causes 20% of cases of...

  Notícias
• February 11 2020

  Shock waves as a treatment for erectile dysfunction

  In recent years, much research has been carried out to find an alternative treatment for erectile dysfunction, other than traditional drug therapy....

  Notícias
• February 20 2020

  Eating fruit, vegetables and fish may help reduce inflammation caused by endometriosis

  Changes in lifestyle, particularly dietary changes, can do a lot to alleviate symptoms for women with endometriosis. Recent studies indicate that e...

  Notícias
• February 28 2020

  Smoking and the risk of gestational diabetes: another reason to quit smoking

  Tobacco is associated with both an increase in the risk of developing type 2 diabetes and there is a clear relationship between smoking during preg...

  Notícias
• March 11 2020

  An effective monoclonal antibody for familial hypercholesterolaemia

  People with familial hypercholesterolaemia find it difficult to reduce their blood cholesterol levels, even when taking the most effective medicine...

  Notícias
• March 30 2020

  Hospital Clínic, Can Ruti and the UB collaborate on the Catalan Health Service's behalf in the development of emergency ventilators to cope with COVID-19

  A team formed by professionals from Hospital Clínic, Germans Trias i Pujol Research Institute and Hospital (IGTP) and the Faculty of Medicine and H...

  Notícias
• April 8 2020

  Smoking increases complications when infected with COVID-19

  SARS-CoV-2 is a virus that affects people with respiratory diseases such as asthma, Chronic Obstructive Pulmonary Disease (COPD) or pulmonary fibro...

  Notícias
• April 21 2020

  Researchers create a low-cost ventilator for areas with limited means

  Researchers from the Respiratory biophysics and bioengineering IDIBAPS research group, the Biophysics and Bioengineering Unit of the UB and the CIB...

  Notícias
• April 30 2020

  The antiviral drug remdesivir reduces the time to recovery in COVID-19 patients

  These are the first results of a global clinical trial in which the Hospital Clinic and ISGlobal participate.

  Notícias
• May 11 2020

  Coronavirus and diabetes. What do the experts recommend?

  Any infection in a person who suffers diabetes has a double risk: on the one hand, it may decompensate the diabetes itself; and on the other, any c...

  Notícias
• May 26 2020

  A new cancer immune therapy spin-off of Hospital Clínic-IDIBAPS secures a 1.5 million-euro investment from Invivo Ventures

  Hospital Clínic – IDIBAPS (Barcelona) has founded Gyala Therapeutics, a new spin-off company focused on developing new CAR-T therapies for treating...

  Notícias